• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News
    • News

    Gates Foundation Funds Hookworm Vaccine Devt

    <i>Reuters tells that the Bill & Melinda Gates Foundation granted $21 million to an initiative that seeks to develop a vaccine against a parasite that brings about severe anemia.</i><br><br>The Bill & Melinda Gates Foundation released $21 million to the Human Hookworm Vaccine Initiative, a project that hopes to develop a substance that would provide immunity against an anemia-cau&#8230;

    By Newswire Newsletter // 09 June 2005

    The Bill & Melinda Gates Foundation released $21 million to the Human Hookworm Vaccine Initiative, a project that hopes to develop a substance that would provide immunity against an anemia-causing parasite. The money will fund human trials undertaken by the partnership between George Washington University and the Sabin Vaccine Institute. According to David Brandling-Bennett, an official at the Gates Foundation, "hookworm is an example of a disease for which a relatively modest investment in research and development could, and we expect will, affect tens of millions of lives." The World Health Organization estimated that around 740 million people worldwide currently carry the parasite, which not only causes anemia but also death of mothers during childbirth in developing countries.

    Source: Bill Gates foundation funds hookworm vaccine effort (Reuters)

    • Funding
    • Global Health
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Newswire Newsletter

      Newswire Newsletter

    Search for articles

    Related Jobs

    • Manager, Regenerative Agriculture
      The Rockefeller Foundation
      New York City, New York, United States | New York, United States | United States | North America
    • Senior Officer, Major Gifts & Planned Giving
      Fos Feminista
      United States | North America
    • Digital Fundraising Lead (Hybrid)
      London, United Kingdom | United Kingdom | Western Europe
    • See more

    Most Read

    • 1
      Opinion: Mobile credit, savings, and insurance can drive financial health
    • 2
      FCDO's top development contractors in 2024/25
    • 3
      Strengthening health systems by measuring what really matters
    • 4
      How AI-powered citizen science can be a catalyst for the SDGs
    • 5
      Opinion: India’s bold leadership in turning the tide for TB

    Trending

    Financing for Development Conference

    The Trump Effect

    Newsletters

    Related Stories

    PhilanthropyRisk-averse Gates bets his fortune on the future

    Risk-averse Gates bets his fortune on the future

    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement